Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update [Yahoo! Finance]
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference [Yahoo! Finance]
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $10.00 to $16.00. They now have a "market outperform" rating on the stock.